NCT04195347View on ClinicalTrials.gov

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

September 4, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2027

Conditions

Acute Pancreatitis

Interventions

DRUG

CM4620

IV

Trial Locations (2)

28204

RECRUITING

Novant Health Presbyterian Hemby Children's Hospital, Charlotte

38105

RECRUITING

St. Jude Children's Research Hospital, Memphis

Sponsors

Collaborators (1)

CalciMedica, Inc.

All Listed Sponsors

collaborator

CalciMedica, Inc.

INDUSTRY

lead

St. Jude Children's Research Hospital

OTHER